Cite
HARVARD Citation
Ho, S. et al. (2023). Ocrelizumab Treatment Modulates B-Cell Regulating Factors in Multiple Sclerosis. Neurology. 10 (2), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ho, S. et al. (2023). Ocrelizumab Treatment Modulates B-Cell Regulating Factors in Multiple Sclerosis. Neurology. 10 (2), p. . [Online].